WELL Health Technologies Corp., a digital healthcare company focused on improving health outcomes through technology and ...
D-Wave Quantum Inc., a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, announced it has achieved "Awardable" status through ...
AbCellera Forward-looking Statements. This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Secur ...
Qmetrix, North America's only provider of Interconnected Commerce solutions for telecom retail, has unveiled two brand-new product suites that it is preparing to launch to market in the coming months, ...
Burcon NutraScience Corporation , a global technology leader in the development of plant-based proteins for foods and beverages, announced the successful completion of a process scale-up project for a ...
Ballard Power Systems announced a purchase order to supply 200 fuel cell engines to New Flyer, a subsidiary of NFI Group Inc.
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...
BuildDirect.com Technologies , a leading omnichannel building material retailer, announced the closing of a secured debt financing in an aggregated amount of approximately $1 Million CDN (US $700,000) ...
Fobi AI Inc., a leader in harnessing AI and data intelligence to enable digital transformation, provided shareholders with a corporate update regarding what it says are the following significant ...
TELUS Global Ventures announced that it is participating in two new funding rounds with equity investments in Homethrive and ...
LUCID Vision Labs, Inc., a leading designer and manufacturer of industrial cameras, announced the launch of the new Triton2 EVS event-based 2.5GigE camera, featuring the IMX636 and IMX637 event-based ...
Jade Biosciences, Inc., a privately held biotechnology company dedicated to developing best-in-class therapies for patients ...